Haleon plc
HealthcareNYSE:HLN · New York Stock Exchange
+$0.11 today
Vol 5.95M · Avg 8.66M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $1.3B |
| Receivables | $2.1B |
| Inventory | $1.0B |
| Other Current | $77.9M |
| Total Current Assets | $4.5B |
| PP&E (Net) | $2.0B |
| Goodwill | $25.6B |
| Long-term Investments | $75.9M |
| Tax Assets | $288.5M |
| Other Non-current | $104.8M |
| Total Non-current Assets | $28.0B |
| Total Assets | $32.6B |
Analysis
Selected assets total $32.6B for Latest. The largest visible component is Goodwill at $25.6B, about 78.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.3B -39.8% | $2.2B +110.2% | $1.0B +52.6% | $684.0M +65.2% | $414.0M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 -100.0% | $55.0M | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $2.1B +11.3% | $1.9B +40.8% | $1.4B -9.1% | $1.5B -61.1% | $3.8B | $533.8M | $399.4M | -$1.7B |
| Inventory | $1.0B -14.0% | $1.2B -15.5% | $1.4B +4.5% | $1.3B +41.7% | $951.0M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $77.9M -65.1% | $223.0M -75.4% | $907.0M +109.0% | $434.0M +8580.0% | $5.0M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $4.5B -20.6% | $5.7B +18.7% | $4.8B +18.7% | $4.1B -22.7% | $5.3B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $2.0B +3.8% | $1.9B +1.0% | $1.9B +0.2% | $1.9B +14.3% | $1.7B | $1.2B | $1.5B | $687.8M |
| Goodwill | $25.6B +211.7% | $8.2B -1.4% | $8.3B -0.9% | $8.4B +1.8% | $8.2B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 -100.0% | $18.0B -2.9% | $18.5B -7.5% | $20.0B +5.8% | $18.9B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $75.9M -7.5% | $82.0M +26.2% | $65.0M +47.7% | $44.0M +91.3% | $23.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $288.5M | $0 | $0 -100.0% | $220.0M -29.5% | $312.0M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $104.8M -72.6% | $383.0M -7.7% | $415.0M +164.3% | $157.0M +1862.5% | $8.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $28.0B -2.0% | $28.6B -2.2% | $29.2B -4.9% | $30.8B +5.3% | $29.2B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $32.6B -5.1% | $34.3B +0.8% | $34.1B -2.2% | $34.8B +1.1% | $34.5B | $13.3B | $11.9B | $10.6B |
| Account Payables | $3.7B +88.7% | $2.0B +6.4% | $1.9B +1.1% | $1.8B +16.2% | $1.6B | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $834.5M -41.9% | $1.4B +136.3% | $608.0M +54.7% | $393.0M -55.0% | $874.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $286.0M -0.7% | $288.0M +37.1% | $210.0M -11.4% | $237.0M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 -100.0% | $23.0M +109.1% | $11.0M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $99.8M -85.6% | $693.0M -55.9% | $1.6B -2.4% | $1.6B +12.7% | $1.4B | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $4.9B -15.3% | $5.8B +25.3% | $4.6B +6.2% | $4.4B +3.1% | $4.2B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $7.8B -9.2% | $8.5B -1.9% | $8.7B -11.9% | $9.9B | $0 | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $3.2B -4.1% | $3.4B -3.8% | $3.5B -3.2% | $3.6B +7.3% | $3.4B | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 -100.0% | $281.0M | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $217.6M -30.0% | $311.0M -26.7% | $424.0M +10.4% | $384.0M | $0 | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $11.2B -8.8% | $12.3B -3.2% | $12.7B -9.3% | $14.0B +274.7% | $3.7B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $16.1B -10.9% | $18.1B +4.4% | $17.3B -5.6% | $18.4B +130.3% | $8.0B | $14.7B | $3.7B | $9.6B |
| Common Stock | $89.8M -1.3% | $91.0M -1.1% | $92.0M +0.0% | $92.0M +9100.0% | $1.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $27.8B +1.9% | $27.3B -0.7% | $27.5B +2.8% | $26.7B -29.6% | $38.0B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 | $0 +100.0% | -$11.0B -1016.4% | $1.2B +110.3% | -$11.6B | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | -$11.5B -3.7% | -$11.1B | $0 +100.0% | -$11.7B | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $58.9M +1.5% | $58.0M -52.8% | $123.0M -2.4% | $126.0M +0.8% | $125.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $16.5B +1.4% | $16.2B -3.0% | $16.7B +1.7% | $16.5B -37.9% | $26.5B | $9.1B | $7.7B | $3.3B |
| Total Debt | $8.6B -14.9% | $10.1B +6.8% | $9.5B -9.4% | $10.4B +953.5% | $991.0M | $724.2M | $410.6M | $399.4M |
| Net Debt | $7.3B -8.0% | $7.9B -6.0% | $8.4B -13.8% | $9.8B +1590.8% | $577.0M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.81B
Cardinal Health, Inc.
NYSE:CAH
$52.30B
Takeda Pharmaceutical Company Limited
NYSE:TAK
$50.48B
Humana Inc.
NYSE:HUM
$45.43B
Agilent Technologies, Inc.
NYSE:A
$36.56B
Zoetis Inc.
NYSE:ZTS
$33.66B
Alcon Inc.
NYSE:ALC
$32.51B
IQVIA Holdings Inc.
NYSE:IQV
$29.85B
ResMed Inc.
NYSE:RMD
$28.03B
Insmed Incorporated
NASDAQ:INSM
$21.22B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does HLN have?
Haleon plc (HLN) reported $1.32B in cash and equivalents in fiscal 2025.
How much debt does HLN carry?
Haleon plc (HLN) reported $8.59B of total debt, with net debt of $7.27B.
Explore More
Continue the stock analysis
Jump to another research area for this company.